Company intelligence / Profile preview

Capwave Sensors

United States

Ownership: Private
Development stage: Other

Overview

CapWave developed a portable biosensor device for rapid pathogen detection with high sensitivity and reduced sample preparation time. The technology utilizes state-of-the-art biosensors in small capillaries with accelerated reaction kinetics to produce quick results.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceBiosensor
Industry: Molecular Diagnostics

Partnerships

SUTIMCo International Inc.Phasiks Inc. (collaboration on thermal control units)

Beyond the preview

Go deeper on Capwave Sensors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capwave Sensors.

Explore the full profile